Cargando…

Tolerance of Tumor-Specific T cells in Melanoma Metastases

Detalles Bibliográficos
Autores principales:	Waugh, Katherine A, Leach, Sonia M, Slansky, Jill E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874257/ https://www.ncbi.nlm.nih.gov/pubmed/27213115 http://dx.doi.org/10.4172/2155-9899.1000409

Ejemplares similares

Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity
por: Waugh, Katherine A., et al.
Publicado: (2015)

Antigen-Specific T Cells: Analyses of the Needles in the Haystack
por: Slansky, Jill E
Publicado: (2003)

Mimotope vaccine efficacy gets a "boost" from native tumor antigens
por: Buhrman, Jonathan D., et al.
Publicado: (2013)

Melanoma with gastric metastases
por: Wong, Katherine, et al.
Publicado: (2016)

Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor
por: Buhrman, Jonathan D., et al.
Publicado: (2013)

Implications of Antigen Selection on T Cell-Based Immunotherapy
por: Camp, Faye A., et al.
Publicado: (2021)

Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases
por: Olino, Kelly, et al.
Publicado: (2011)

Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
por: Trembath, Dimitri G., et al.
Publicado: (2021)

Cerebral metastases of cutaneous melanoma.
por: Gupta, G., et al.
Publicado: (1997)

Intracranial Tumor Cell Migration and the Development of Multiple Brain Metastases in Malignant Melanoma()()
por: Simonsen, Trude G., et al.
Publicado: (2016)

Antigen presentation by tumor infiltrating B cells influences CD4 T cell phenotype and function in primary lung cancer patient tumors
por: Bruno, Tullia, et al.
Publicado: (2015)

TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines
por: Jordan, Kimberly R., et al.
Publicado: (2012)

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma
por: Papp, Orsolya, et al.
Publicado: (2021)

The Goldilocks Model for TCR—Too Much Attraction Might Not Be Best for Vaccine Design
por: Slansky, Jill E., et al.
Publicado: (2010)

Treated Choroidal Melanoma with Late Metastases to the Contralateral Orbit
por: George, Sonia, et al.
Publicado: (2009)

Unusual metastases of melanoma
por: Carillio, Guido, et al.
Publicado: (2018)

Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma
por: Robinson, Helena, et al.
Publicado: (2023)

Local and Recurrent Regional Metastases of Melanoma
por: Perez, Matthew C., et al.
Publicado: (2019)

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases
por: In, Gino K., et al.
Publicado: (2020)

Melanoma metastases caught in the AKT
por: Kircher, David A., et al.
Publicado: (2016)

Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity
por: Hay, Zachary L. Z., et al.
Publicado: (2022)

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas
por: Gassenmaier, Maximilian, et al.
Publicado: (2021)

Lymph protects metastasizing melanoma cells from ferroptosis
por: Ubellacker, Jessalyn M., et al.
Publicado: (2020)

Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
por: Salzmann, Martin, et al.
Publicado: (2023)

Tracking and Treating Malignant Melanoma Metastases
por: Piérard, Gérald E., et al.
Publicado: (2012)

Metastases of malignant melanoma to stomach
por: Kuzu, Ufuk Barıs, et al.
Publicado: (2016)

MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008)

Primary Regressive, But Metastasizing Melanoma!?
por: Tchernev, Georgi, et al.
Publicado: (2019)

Transient T cell depletion causes regression of melanoma metastases
por: Rasku, Mary Ann, et al.
Publicado: (2008)

Human melanoma-specific CD8(+) T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo
por: Mahnke, Yolanda D., et al.
Publicado: (2012)

Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases
por: Wesslau, Hanna, et al.
Publicado: (2022)

Low TCR Binding Strength Results in Increased Progenitor-like CD8(+) Tumor-Infiltrating Lymphocytes
por: Hay, Zachary L.Z., et al.
Publicado: (2023)

Cardiac Metastases from Choroidal Melanoma
por: Madani, Ammar, et al.
Publicado: (2022)

Tumoral inflammatory infiltrate does not predict metastases in thin primary cutaneous melanomas()
por: Bevilaqua, Mariele, et al.
Publicado: (2023)

Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes
Publicado: (1981)

Targeting Brain Metastases in Patients with Melanoma
por: Papadatos-Pastos, Dionysis, et al.
Publicado: (2013)

Immunomodulatory Drugs in Melanoma Brain Metastases
por: Fernandes, Gil Nuno Castro
Publicado: (2019)

Outcomes of Treatment for Melanoma Brain Metastases
por: Janavicius, Mantas, et al.
Publicado: (2020)

Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure
por: Tringale, Kathryn R, et al.
Publicado: (2023)

Carboxyl nanodiamonds inhibit melanoma tumor metastases by blocking cellular motility and invasiveness
por: Behera, Sushreesangita P, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kdqfg1gm0c8f2jr6t85egkdj83